Company Search:
Advanced Search
Sponsored Links
Zhejiang Hisun Pharmaceutical, Ltd. Company Snapshot
Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other companies in this sector in China: Chongqing Taiji Industry (Group) (2018 sales of 10.69 billion Chinese Renmimbi [US$1.59 billion] of which 74% was Industrial), WuXi AppTec Co Ltd (9.61 billion Chinese Renmimbi [US$1.43 billion] ), and Huapont-Nutrichem Co Ltd (10.57 billion Chinese Renmimbi [US$1.58 billion] of which 65% was Agricultural Business).

Sales Analysis. Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 10.09 billion Chinese Renmimbi (US$1.50 billion) for the year ending December of 2018. This represents a decrease of 4.6% versus 2017, when the company's sales were 10.57 billion Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhejiang Hisun Pharmaceutical, Ltd.
  Stock Performance Chart for Zhejiang Hisun Pharmaceutical, Ltd.
  Stock Data: Recent Stock Performance:
  Current Price (4/19/2019): 11.91
(Figures in Chinese Renmimbi)
1 Week -2.0%   13 Weeks 5.4%  
4 Weeks 40.6%   52 Weeks -21.5%  
Zhejiang Hisun Pharmaceutical, Ltd. Key Data:
  Ticker: 600267 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 10,088,773,125
(Year Ending Jan 2019).
Employees: 9,497
  Currency: Chinese Renmimbi Market Cap: 11,499,484,238
  Fiscal Yr Ends: December Shares Outstanding: 965,531,842
  Share Type: A Gu Closely Held Shares: 443,466,303
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.